COMPANY PROFILE // THE 014 REPORT

Centessa Pharmaceuticals plc

Formerly: Centessa Pharmaceuticals Ltd

Assembled from 2 government sources in 2.5 s

Built from public records at 2026-11-22 05:01 ET. Every figure links to its source. Flags and checks built 2026-11-22 05:01 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

  • Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-06-24 (last 24 months).2026-06-24 · source
  • Amber4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-24: a pattern of leadership change.2026-06-24 · source

✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration

No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.

Centessa Pharmaceuticals plc is an SEC-registered operating company in pharmaceutical preparations, incorporated in United Kingdom, based in Altrincham, Cheshire, United Kingdom.[source] It reported revenue of $15.0 million for the fiscal year ended 2025-12-31.[source] It has filed 92 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-08-14.[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; 4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-24.[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
92SEC filings in the last 12 months
0value held by 13F filers in our records
SEC filings by month, 24 months
2024-12: 192025-01: 82025-02: 212025-03: 112025-04: 92025-05: 132025-06: 202025-07: 102025-08: 62025-09: 142025-10: 52025-11: 192025-12: 52026-01: 42026-02: 122026-03: 212026-04: 42026-05: 82026-06: 292026-07: 22026-08: 42026-09: 02026-10: 02026-11: 02024-122026-11
Flags by level
  • red0
  • amber2
  • info0
Lists and sources checked, by result
  • CLEAR26
  • POSSIBLE MATCH0
  • MATCH0

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001847903source
EIN00-0000000source
Business address (SEC)3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, X0, WA14 2DTsource

Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

PEERS BY SIC CODE

Industry context

SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.

Peers, each with its 014

  • PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
  • Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
  • ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
  • ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
  • TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
  • NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
  • Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
  • Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
  • SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
  • Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
  • UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
  • Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)

EVERY SOURCE · NEWEST FIRST

One timeline

168 earlier entries
DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.

PRICE · FILINGS · POSTS · NEWS

Market & news

Price
No listing symbol is held for this company.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

0confirmed members (SEC registrant + GLEIF ownership tree)
0legal entities (LEI) in the ownership tree
25dated filings and events

0 possible matches held apart, matched by name only, not counted above.

IdentifierValueHow it was resolvedSource
SEC CIK1847903id:sec-anchor: the SEC registrant record of this companySEC EDGAR
CUSIP152309100carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001847903SEC EDGAR

The company table did not answer, so only the identifiers carried on the SEC record are shown.

Next: reload in a minute, or open the record page.

AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Revenue (fiscal year ended 2025-12-31)$15,000,0002025-12-3110-K, XBRL Revenuesas filed2026-11-22 10:01 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)-$197,532,0002025-12-3110-K, XBRL NetIncomeLossas filed2026-11-22 10:01 UTCReport an error
Total assets (at 2025-12-31)$687,495,0002025-12-3110-K, XBRL Assetsas filed2026-11-22 10:01 UTCReport an error
Stockholders' equity (at 2025-12-31)$526,863,0002025-12-3110-K, XBRL StockholdersEquityas filed2026-11-22 10:01 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$61,299,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValueas filed2026-11-22 10:01 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeoperating2026-08-14SEC EDGAR company profileas filed2026-11-22 10:01 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-08-14SEC EDGAR company profileas filed2026-11-22 10:01 UTCReport an error
State of incorporationX02026-08-14SEC EDGAR company profileas filed2026-11-22 10:01 UTCReport an error
Fiscal year end (MMDD)12312026-08-14SEC EDGAR company profileas filed2026-11-22 10:01 UTCReport an error
Business address3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, X0, WA14 2DT2026-08-14SEC EDGAR company profileas filed2026-11-22 10:01 UTCReport an error

Other filed values

FigureValuePeriod or as ofSourceBasisRetrievedReport
Operating cash flow (fiscal year ended 2025-12-31)-$193,817,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivitiesas filed2026-11-22 10:01 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$371,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipmentas filed2026-11-22 10:01 UTCReport an error
Long-term debt (at 2025-12-31)$110,095,0002025-12-3110-K, XBRL LongTermDebtas filed2026-11-22 10:01 UTCReport an error
Operating lease liabilities (at 2025-12-31)$8,286,0002025-12-3110-K, XBRL OperatingLeaseLiabilityas filed2026-11-22 10:01 UTCReport an error

Latest report: 10-Q for the period ended 2026-03-31, filed 2026-05-05 · accession 0001847903-26-000049

Old data: the newest 10-Q or 10-K in SEC company facts has no later XBRL values.

ItemValuePeriodFormFiledAccessionRetrievedReport
Revenue$03 months ended 2026-03-3110-Q2026-05-050001847903-26-0000492026-11-22 10:01 UTCReport an error
Net income (loss)-$79,241,0003 months ended 2026-03-3110-Q2026-05-050001847903-26-0000492026-11-22 10:01 UTCReport an error
Interest expense$2,731,0003 months ended 2026-03-3110-Q2026-05-050001847903-26-0000492026-11-22 10:01 UTCReport an error
Cash and cash equivalents$62,431,000at 2026-03-3110-Q2026-05-050001847903-26-0000492026-11-22 10:01 UTCReport an error
Debt due in the next 12 months$0at 2026-03-3110-Q2026-05-050001847903-26-0000492026-11-22 10:01 UTCReport an error
Debt due in year 2$115,500,000at 2026-03-3110-Q2026-05-050001847903-26-0000492026-11-22 10:01 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

WHAT THIS PAGE READ

Sources

As of 2026-11-22 (record built 2026-11-22T10:01:18Z). Sources used: SEC EDGAR, SEC 13F holdings.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1847903.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001847903. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.